Page 761 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

6 References

173. Clark JG, Milberg JA, Steinberg KP, Hudson LD. Type III 193. Sonnenberg GF, Monticelli LA, Alenghat T, et al. Innate
pro-collagen peptide in the adult respiratory distress syndrome. lymphoid cells promote anatomical containment of lymphoid-
Association of increased peptide levels in bronchoalveolar lavage resident commensal bacteria. Science. 2012;336:1321.
fluid with increased risk for death. Ann Intern Med. 1995;122:17. 194. Neill DR, Wong SH, Bellosi A, et al. Nuocytes represent a
174. Marshall RP, Bellingan G, Webb S, et al. Fibroproliferation new innate effector leukocyte that mediates type-2 immunity.
occurs early in the acute respiratory distress syndrome and Nature. 2010;464:1367.
impacts on outcome. Am J Respir Crit Care Med. 2000;162:1783. 195. Moro K, Yamada T, Tanabe M, et al. Innate production of
175. Clark JG, Milberg JA, Steinberg KP, Hudson LD. Elevated T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+)
lavage levels of N-terminal peptide of type III procollagen are lymphoid cells. Nature. 2010;463:540.
associated with increased fatality in adult respiratory distress 196. Price AE, Liang HE, Sullivan BM, et al. Systemically dispersed
syndrome. Chest. 1994;3:126S. innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad
176. Toews GB. Cellular alterations in fibroproliferative lung disease Sci U S A. 2010;107:11489.
[review]. Chest. 1999;116:112S. 197. Chang YJ, Kim HY, Albacker LA, et al. Innate lymphoid cells
177. Zhu HJ, Burgess AW. Regulation of transforming growth factor- mediate influenza-induced airway hyper-reactivity indepen-
beta signaling [review]. Mol Cell Biol Res Commun. 2001;4:321. dently of adaptive immunity. Nat Immunol. 2011;12:631.
178. Madtes DK, Rubenfeld G, Klima LD, et al. Elevated transform- 198. Scandella E, Bolinger B, Lattmann E, et al. Restoration of lymphoid
ing growth factor-alpha levels in bronchoalveolar lavage fluid of organ integrity through the interaction of lymphoid tissue-inducer
patients with acute respiratory distress syndrome. Am J Respir cells with stroma of the T cell zone. Nat Immunol. 2008;9:667.
Crit Care Med. 1998;158:424. 199. Monticelli LA, Sonnenberg GF, Artis D. Innate lymphoid cells:
179. Jain M, Budinger GRS, Lo A, Urich D. Leptin promotes fibro- critical regulators of allergic inflammation and tissue repair in
proliferative acute respiratory distress syndrome by inhibiting the lung. Curr Opin Immunol. 2011;24:284.
peroxisome proliferators-activated receptor-γ. Am J Respir Crit 200. Monticelli LA, Sonnenberg GF, Abt MC, et al. Innate lymphoid
Care Med. 2011;183:1490. cells promote lung-tissue homeostasis after infection with
180. Woods A. Syndecans: transmembrane modulators of adhesion influenza virus. Nat Immunol. 2011;12:1045.
and matrix assembly. J Clin Invest. 2001;107:935. 201. Matthay MA, Folkesson HG, Clerici C. Lung epithelial fluid
181. Bensadoun ES, Burke AK, Hogg JC, Roberts CR. Proteoglycan transport and the resolution of pulmonary edema [review].
deposition in pulmonary fibrosis. Am J Respir Crit Care Med. Physiol Rev. 2002;82:569.
1996;154:1819. 202. Sakuma T, Okaniwa G, Nakada T, et al. Alveolar fluid clearance
182. Savani RC, Hou G, Liu P, et al. A role for hyaluronan in macro- in the resected human lung [see comment]. Am J Respir Crit
phage accumulation and collagen deposition after bleomycin- Care Med. 1994;150:305.
induced lung injury. Am J Respir Cell Mol Biol. 2000;23:475. 203. Sakuma T, Folkesson HG, Suzuki S, et al. Beta-adrenergic ago-
183. Bornstein P. Thrombospondins as matricellular modulators of nist stimulated alveolar fluid clearance in ex vivo human and rat
cell function. J Clin Invest. 2001;107:929. lungs. Am J Respir Crit Care Med. 1997;155:506.
184. Murphy-Ullrich JE. The de-adhesive activity of matricellular 204. Suzuki S, Noda M, Sugita M, et al. Impairment of transalveolar
proteins: is intermediate cell adhesion an adaptive state? [see fluid transport and lung Na(+)-K(+)-ATPase function by
comment] [review]. J Clin Invest. 2001;107:785. hypoxia in rats. J Appl Physiol. 1999;87:962.
185. Shapiro SD, Senior RM. Matrix metalloproteinases. Matrix deg- 205. Vivona ML, Matthay M, Chabaud MB, et al. Hypoxia reduces
radation and more. Am J Respir Cell Mol Biol. 1999;20:1100. alveolar epithelial sodium and fluid transport in rats: reversal
by beta-adrenergic agonist treatment. Am J Respir Cell Mol Biol.
186. Buckley CD, Gilroy DW, Serhan CN, et al. The resolution of 2001;25:554.
inflammation. Nat Rev Immunol. 2013;13:59. 206. Hu P, Ischiropoulos H, Beckman JS, Matalon S. Peroxynitrite
187. Pietropaoli A, Georas SN. Resolving lung injury: a new role for inhibition of oxygen consumption and sodium transport in
Tregs in controlling the innate immune response. J Clin Invest. alveolar type II cells. Am J Physiol. 1994;266:L628.
2009;119:2891. 207. Greene KE, Wright JR, Steinberg KP, et al. Serial changes in sur-
188. D’Alessio F, Tsushima K, Aggarwal NR, et al. CD4+CD25 factant associated proteins in lung and serum before and after
+Foxp3+ Tregs resolve experimental lung injury in mice and onset of ARDS. Am J Respir Crit Care Med. 1999;160:1843.
are present in humans with acute lung injury. J Clin Invest. 208. Greene KE, Ye S, Mason RJ, et al. Serum surfactant protein-A
2009;119:2891.
levels predict development of ARDS in at-risk patients. Chest.
189. Beers MF, Morrisey EE. The three R’s of lung health and 1999;116:90S.
disease: repair, remodeling, and regeneration. J Clin Invest. 209. Kropski JA, Fremont RD, Calfee CS, et al. Clara cell protein
2011;121:2065.
(CC16), a marker of lung epithelial injury, is decreased in
190. Kajstura J, Rota M, Hall SR, et al. Evidence for human lung stem plasma and pulmonary edema fluid from patients with acute
cells. N Engl J Med. 2011;364:1795. lung injury. Chest. 2009;135:1440.
191. Spits H, Cupedo T. Innate lymphoid cells: emerging insights 210. Calfee CS,Ware LB, Eisner MD, et al. Plasma receptor for
in development, lineage relationships, and function. Annu Rev advanced glycation end products and clinical outcomes in acute
Immunol. 2012;30:647. lung injury. Thorax. 2008;63:1083.
192. Sonnenberg GF, Monticelli LA, Elloso MM, Fouser LA, Artis D. 211. Verghese GM, Ware LB, Matthay BA, Matthay MA. Alveolar
CD4(+) lymphoid tissue-inducer cells promote innate immunity epithelial fluid transport and the resolution of clinically severe
in the gut. Immunity. 2011;34:122. hydrostatic pulmonary edema. J Appl Physiol. 1999;87:1301.

Section04-O-ref.indd 6 1/21/2015 11:23:18 AM